DOJ's Dilemma: Granston Motions are on the Rise… But Not Always Met with Swift Justice
Client Alert | 2 min read | 07.12.19
On July 3, 2019, in United States ex rel. Johnson v. Raytheon Co., the U.S. District Court for the Northern District of Texas granted the government’s motion to dismiss a qui tam suit over the objections of the relator. The Johnson case is just the latest example of the Department of Justice (DOJ) using its authority under Section 3730(c)(2)(A) of the False Claims Act to seek dismissal of meritless qui tam suits, consistent with a January 2018 DOJ Memorandum emphasizing the importance of that authority (the “Granston memo”).
The wave of Section 3730(C)(2)(A) motions filed since the release of the Granston memo have resulted in more than 30 decisions across the country with courts coalescing around two standards of judicial review — the Swift and Sequoia Orange standards. The ruling of the U.S. Court of Appeals for the District of Columbia Circuit in Swift v. U.S. recognizes that DOJ’s right to dismiss is essentially unfettered. In contrast, the U.S. Court of Appeals for the Ninth Circuit’s standard, established in Sequoia Orange v. Baird-Neece Packing Corp., requires that DOJ identify a valid purpose for dismissal and show a “rational relation” between the dismissal and accomplishing that purpose.
The majority of DOJ’s 3730(C)(2)(A) motions have been granted, but the 18 months since the release of the Granston memo have not been without setbacks for the government. Last month, the U.S. District Court for the Southern District of Illinois rejected the government’s request that the court alter an order in United States ex rel CIMZNHCA v. UCB, in which the court applied Sequoia Orange and denied DOJ’s motion to dismiss. That decision is noteworthy because the government is appealing the ruling to the Seventh Circuit, and CIMZNHCA is one of 10 nearly identical lawsuits filed by the National Healthcare Analysis Group (NHCA) that DOJ had moved to dismiss.
In an Expert Analysis article published in Law360, C&M attorneys provide an overview of the rise in Section 3730(c)(2)(A) motions and analyze the NHCA lawsuits as a case study on the government’s efforts to curb meritless qui tam actions.
Contacts
Insights
Client Alert | 7 min read | 10.29.26
On 8 October 2026, Crowell & Moring, King's College London, and the Competition Law Center at George Washington University co-hosted the 7th EU Competition Law Conference at De Warande in Brussels. Mark Meador, Commissioner at the US Federal Trade Commission (FTC), delivered the opening keynote address, followed by four panels bringing together practitioners, regulators, academics, and in-house counsel to discuss the latest developments in EU, UK, and US competition law enforcement. Among other things, the panels examined algorithmic pricing; the European Commission's (Commission) new guidelines on exclusionary abuses under Article 102 TFEU (Article 102 Guidelines); the impact of dominant positions in merger reviews; and lessons from the enforcement of the Digital Markets Act (DMA) and the UK’s Digital Markets, Competition and Consumers Act.
Client Alert | 2 min read | 10.28.26
Debriefing to Dead Briefing: How to Avoid Dismissal by Identifying “Required” Debriefings
Client Alert | 7 min read | 10.27.26
Client Alert | 5 min read | 10.27.26
The UK Defence Footprint 2026 and the Warsaw Defence Plan: Investment, Innovation and Opportunities


